MERCK KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170.30 EUR | +0.24% |
|
-2.10% | +18.18% |
| 09-09 | German Shares Cheer Likelihood of September ECB Rate Cut | MT |
| 09-03 | Merck Gets EU Approval for Keytruda Cancer Therapy | DJ |
Chart calendar Merck KGaA
e178ca14b4e6c2ca2b1b96e8aac7db3.ngHJDW-cLh9TPDMQYy7Far7LKcxxRmTqbVYFrF2GZCA.zVeEPwypZEceZgJiL3-yP9mhdoILFlKCLGdRwnDHDE7fU_l5P9hmXQF4RA~cef00f78737547dc26694180173b6c1f
Upcoming events on Merck KGaA
Past events on Merck KGaA
| 2024-08-01 08:00 | Q2 2024 Earnings Call |
| 2024-08-01 01:00 | Q2 2024 Earnings Release |
| 2024-06-03 14:30 | American Society of Clinical Oncology Meeting - Abstract No - 8575 |
| 2024-06-03 11:12 | American Society of Clinical Oncology Meeting - Abstract No - 4508 |
| 2024-06-03 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 3018 |
| 2024-06-03 09:00 | R&D Day |
| 2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 4567 |
| 2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 4566 |
| 2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - TPS6126 |
| 2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No - LBA3559 |
| 2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No - 3550 |
| 2024-06-01 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 2614 |
| 2024-06-01 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 2612 |
| 2024-06-01 04:00 | American Society of Clinical Oncology Meeting - Abstract No - 3000 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - e18039 |
| 2024-05-15 08:00 | Q1 2024 Earnings Call |
| 2024-05-15 01:00 | Q1 2024 Earnings Release |
| 2024-04-28 | Détachement de for final dividend |
| 2024-04-26 04:00 | Annual General Meeting |
| 2024-03-07 08:00 | Q4 2023 Earnings Call |
Past dividends on Merck KGaA
| 2024-04-28 | Annual 2.2 EUR |
| 2023-05-01 | Annual 2.2 EUR |
| 2022-04-24 | Annual 1.85 EUR |
| 2021-04-25 | Annual 1.4 EUR |
| 2020-05-28 | Annual 1.3 EUR |
| 2019-04-28 | Annual 1.25 EUR |
| 2018-04-29 | Annual 1.25 EUR |
| 2017-05-01 | Annual 1.2 EUR |
| 2016-05-01 | Annual 1.05 EUR |
| 2015-04-19 | Annual 1 EUR |
| 2014-05-11 | Annual 1.9 EUR |
| 2013-04-28 | Annual 1.7 EUR |
| 2012-04-22 | Annual 1.5 EUR |
| 2011-04-10 | Annual 1.25 EUR |
| 2010-04-11 | Annual 1 EUR |
| 2009-04-05 | Annual 1.5 EUR |
| 2008-03-30 | Annual 1.2 EUR |
| 2008-03-30 | Bonus Payment 2 EUR |
| 2007-04-29 | Bonus Payment 0.15 EUR |
| 2007-04-29 | Annual 0.9 EUR |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 19 687 19 632 0.28% | 22 232 22 259 -0.12% | 20 993 21 026 -0.16% | 21 408 | 22 581 | 23 650 |
|
EBITDA Million EUR | Released Forecast Spread | 6 103 6 096 0.12% | 6 849 6 898 -0.71% | 5 879 5 823 0.97% | 6 055 | 6 706 | 7 214 |
|
EBIT Million EUR | Released Forecast Spread | 4 179 4 150 0.69% | 4 474 4 933 -9.29% | 3 609 3 730 -3.24% | 3 907 | 4 644 | 5 096 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 3 924 3 886 0.97% | 4 287 4 727 -9.3% | 3 484 3 695 -5.72% | 3 783 | 4 507 | 4 957 |
|
Net income Million EUR | Released Forecast Spread | 3 055 2 986 2.3% | 3 326 3 674 -9.48% | 2 824 2 831 -0.26% | 2 994 | 3 557 | 3 908 |
|
EPS EUR | Released Forecast Spread | 7,03 6,89 2.1% | 7,65 8,46 -9.54% | 6,49 6,50 -0.22% | 6,88 | 8,22 | 9,07 |
| Announcement Date | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5 806 5 695 1.95% | 5 660 5 698 -0.66% | 5 293 5 254 0.73% | 5 302 5 221 1.55% | 5 173 5 255 -1.56% | 5 225 5 248 -0.44% | 5 120 5 144 -0.47% | 5 352 5 248 1.98% | 5 437 | 5 500 |
|
EBITDA Million EUR | Released Forecast Spread | 1 811 1 795 0.85% | 1 628 1 658 -1.83% | 1 587 1 550 2.41% | 1 553 1 511 2.76% | 1 446 1 369 5.66% | 1 293 1 256 2.95% | 1 454 1 354 7.38% | 1 509 1 413 6.78% | 1 570 | 1 597 |
|
EBIT Million EUR | Released Forecast Spread | 1 234 1 319 -6.45% | 890 1 241 -28.29% | 1 035 1 124 -7.95% | 969 1 028 -5.7% | 983 903 8.89% | 621 750 -17.18% | 931 815 14.21% | 792 822 -3.64% | ||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 187 1 266 -6.26% | 839 1 202 -30.19% | 1 012 1 088 -7.01% | 894 981 -8.88% | 937 850 10.29% | 641 839 -23.56% | 899 785 14.55% | 785 797 -1.48% | ||
|
Net income Million EUR | Released Forecast Spread | 923 980 -5.76% | 655 967 -32.26% | 796 825 -3.53% | 704 765 -8% | 739 658 12.37% | 586 647 -9.4% | 694 657 5.6% | 607 619 -1.89% | 862 | 1 022 |
|
EPS EUR | Released Forecast Spread | 2,12 2,27 -6.43% | 1,51 2,22 -32.06% | 1,83 1,90 -3.6% | 1,62 1,76 -8.06% | 1,70 1,54 10.21% | 1,34 1,50 -10.42% | 1,60 1,52 5.02% | 1,40 1,41 -0.93% | 1,98 | 2,35 |
| Announcement Date | 10/11/22 | 02/03/23 | 11/05/23 | 03/08/23 | 09/11/23 | 07/03/24 | 15/05/24 | 01/08/24 | - | - |
More events
Past sector events for Merck KGaA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck KGaA
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition